United States · Investor

Devon Park BioVentures

No cheque observed since May 2014, after 12 earlier cheques, and the website is dead.

DormantGrowth equity

Series DSeries CSeries A

Cheques on record
0%of best year0cheques in 12 months, 12 on record
Since the last cheque4547days00hrs00min00sec
Median round$24MRounds led0 of 12Exits1 from the portfolioMostly inUnited States, 100%
Pitch Devon Park BioVentures

Devon Park BioVentures highlights

  1. 01

    12 rounds on record

  2. 02

    Mostly Series D and Series C: 58% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first12 appearances

  1. 2014

    2 rounds

  2. May
    Proteon TherapeuticsSeries D · US$45MWith 9 others
  3. Mar
    ZS PharmaSeries D · US$55MWith 8 others
  4. 2013

    2 rounds

  5. Sept
    Inotek PharmaceuticalsDebt · US · inotekcorp.com$7.0MWith 5 others
  6. Aug
    MicuRx PharmaceuticalsSeries B · US · finsmes.com$25MWith 2 others
  7. 2012

    3 rounds

  8. Oct
    ZS PharmaSeries C · US · bizjournals.com$46MWith 5 others
  9. Mar
    Cardeas PharmaSeries A · US$7.5MWith 2 others
  10. Feb
    Vascular MagneticsSeries A · US · fiercebiotech.com$7.0MWith 1 other
  11. 2011

    1 round

  12. Jul
    Inotek PharmaceuticalsSeries D · US · sec.gov$24MWith 4 others
  13. 2010

    1 round

  14. Jul
    Cara TherapeuticsSeries D · US · fiercebiotech.com$15MWith 7 others
  15. 2009

    2 rounds

  16. Jun
    CempraSeries C · US · onbiovc.com$46MWith 5 others
  17. May
    Proteon TherapeuticsSeries B · US · proteontherapeutics.com$50MWith 7 others
  18. 2008

    1 round

  19. Jul
    Cara TherapeuticsSeries C · US$12MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

ZS PharmaBought by AstraZeneca$2.7BNov 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Devon Park BioVentures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Devon Park BioVentures

What does Devon Park BioVentures invest in?

Devon Park BioVentures invests most often at Series D and Series C (58% of the rounds on record).

How active is Devon Park BioVentures?

12 investments on record, 0 of them in the last 12 months. The most recent was in May 2014.

How big are Devon Park BioVentures's cheques?

The median round it joins is $24M.

Does Devon Park BioVentures lead rounds?

Rarely, if at all: none of its 12 investments on record names it as the lead.

Where does Devon Park BioVentures invest?

Most of the companies it backs are in the United States (100%).

Is Devon Park BioVentures investing now?

It looks quiet: no investment on record since May 2014.

Who does Devon Park BioVentures invest alongside?

Most often Alta Partners (3 rounds together), Intersouth Partners (3 rounds together) and 3x5 Special Opportunity Fund (2 rounds together).

What kind of investor is Devon Park BioVentures?

Devon Park BioVentures is a growth equity firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it